Class I major histocompatibility antigens in humans (HLA antigens) were found to participate in the regulation of T-cell activation and proliferation induced by phytohemagglutinin. W6/32, a monomorphic antibody directed against class I HLA-A,B,C antigens, significantly inhibited the phytohemagglutinin-induced cell proliferation of peripheral blood lymphocytes. Almost complete suppression of cell activation was achieved on a subfraction of peripheral blood lymphocytes enriched in Mo1+ monocyte/macrophage cells.
demonstrated that the expression of receptors for interleukin 2 and transferrin was impaired in the presence of antibody. Although the amount of interleukin 2 synthesized by these cells was also reduced, the addition of exogenous purified interleukin 2 did not restore cell proliferation. Mitogenesis induced by the Ca2+ ionophore A23187 was similarly suppressed, but mitogenesis induced by the phorbol diester phorbol myristate acetate, which activates cells by directly stimulating protein kinase C, was not suppressed. These results are consistent with a hypothesis that HLA class I antigens regulate an early event(s) of the Ca2+-dependent pathway of activation of T lymphocytes and that this event(s) apparently occurs before protein kinase C stimulation.
T-cell activation plays a central role in the immune response. This response, in vivo, is elicited by the presentation of viruses or other antigens and is mediated via the T3 glycoprotein-antigen receptor complex (1) . In vitro, T-cell proliferation can be induced in a variety of ways-e.g., by antigen presentation in mixed lymphocyte reactions or by use of monoclonal antibodies (mAbs) against certain T-cell surface antigens such as T3 and T11 (2) (3) (4) . Chemicals such as calcium ionophore A23187, phorbol 12-myristate 13 -acetate (PMA), or mitogenic lectins like phytohemagglutinin (PHA), also induce T-cell responses (5) (6) (7) . On the other hand, antibodies directed against cell surface determinants like T8, lymphocyte function-associated (LFA) molecules, 832-microglobulin (f32m), and class I and II histocompatibility antigens (8) (9) (10) (11) (12) (13) (14) interfere with T-cell activation.
Genetic studies have established that class II major histocompatibility complex products typically restrict antigen presentation and T-cell activation, while class I antigens restrict cytotoxicity of T cells to viral or other antigens (2) .
However, direct experiments with mAbs against these antigens and ,82m show that, like class II antigens, class I antigens are also involved in the processes leading to T-cell activation and proliferation (10) (11) (12) (13) (14) . Interestingly, anti-p2m may inhibit the primary mixed lymphocyte reaction by suppressing interleukin-2 (IL-2) production and not the IL-2 responsiveness of T cells (13) . In contrast, anti-class I antibody is reported to inhibit the IL-2 receptor expression on T cells activated by an anti-T3 antibody, while IL-2 production by these cells is not affected (14) .
Since T cells are also activated by mitogenic lectins, we wanted to determine whether an anti-class I antibody could block such activation, and, if so, by which mechanism. The results presented here demonstrate that the antibody suppresses cell proliferation by interfering with the Ca2+-dependent pathway of activation. It inhibits IL-2 production and prevents the expression ofIL-2 and transferrin receptors. This inhibitory effect of anti-HLA-class I antibody on T-cell activation is dependent upon the presence of adherent cells. Indirect Immunofluorescence Analysis. Cells (1.5 X 106) were incubated with appropriate dilutions of mAbs or with culture medium at 4°C for 30 min and washed twice with L-glutamine/penicillin/streptomycin-supplemented RPMI 1640 medium containing 0.02% sodium azide (RPMI azide). Cells were then incubated for an additional 30 min with a 1:30 dilution of fluorescein isothiocyanate-conjugated goat antimouse IgG (Bionetics Laboratory Products, Kensington, MD) at 4°C. After the cells were washed in RPMI azide, they were resuspended in 1 ml of medium containing azide. The fluorescence data were obtained by using forward lightscatter intensity measurements on a Coulter Epics V Counter.
METHODS AND MATERIALS
Measurement of IL-2 Production. Forty-eight-hour culture supernatants were centrifuged for 10 min in an Eppendorf centrifuge (15,000 x g) and then stored at -20°C. To measure IL-2 activity, 5000 murine IL-2-dependent cytotoxic T lymphocytes (CTL) (21) values within parentheses represent the interfaces of the density gradient. Wherever necessary, the corresponding Percoll-density interfaces will also be mentioned with these fraction numbers. When cells from these fractions were incubated with PHA in the presence of W6/32 at 25 gg/ml, the inhibition of proliferation ranged from 93% for fraction 1 to 23% for fraction 4 ( Table 1 ). The F(ab')2 fragment ofW6/32 also significantly suppressed the activation of fraction 1 (P < 0.001, Student t test). This also shows that the suppression was not Fc receptor-mediated.
To examine if the high level of inhibition of cell proliferation in Percoll fraction 1 (45/50%) was due to antibodydependent cell cytotoxicity, 51Cr-labeled lymphoblastoid B cells were added in a 20:1 effector/target ratio 2 hr after addition of PHA (1 FLg/ml) and W6/32 (25 Atg/ml). Chromium release was measured after 18 hr of further incubation. A parallel assay measured the inhibition of PHA-induced cell proliferation by W6/32. While the mitogenic response was suppressed by 97%, cell cytotoxicity was suppressed only 2%. Hence, ADCC cannot explain the observed suppression of T-cell activation by anti-HLA-class I antibody. Fig. 2 Left shows the dose-dependency of inhibition of PHA activation. Antibody concentrations that almost completely suppressed the proliferative response of fraction 1 only partially suppressed PBL activation. The effects of adding antibody at different times after activation of fraction 1 cells are shown in Fig. 2 (17) , they are probably not involved in the suppression of T-cell activation seen here because the adherent cells used in these experiments were obtained after two cycles of plastic adherence, and null cells are generally nonadherent (17) . Hence, the inhibition of T-cell activation is primarily mediated by macrophage/monocyte-type adherent cells. to PHA; thymidine incorporation by precoated or uncoated T cells remained the same. Even the addition of adherent cells to the precoated T cells (T*) gave the same level of increase in mitogenic response as in the case of addition to the uncoated normal T cells. Thus, the inhibition of T-cell proliferation in the presence of anti-class I antibody is neither due to the cytotoxic effects of macrophages nor to the hindrance of PHA interaction with T cells by the presence of antibody on them. Effects of Antibody on IL Production. Since T-cell proliferation depends upon the production of IL-1 by macrophages (22) and subsequent release of IL-2 by T lymphocytes (30) , experiments were performed to determine if IL-2 production is suppressed in the presence of W6/32 and if exogenously added IL-1 and IL-2 could overcome this suppression. There were appreciable differences in the amounts ofIL-2 produced in the presence and absence of antibody (Table 3 ). The level of IL-2 produced when cells were incubated with W6/32 fell sharply.
To test if the suppression of T-cell proliferation could be reversed by the addition ofexogenous IL-2, purified IL-2 was added to the cultures. Exogenously added IL-2 did not decrease the level of antibody-mediated inhibition (Fig. 3) , nor could the addition of exogenous IL-1 reverse the suppression of cell proliferation. Effect of Antibody on the Expression of IL-2 and Transferrin Receptors. T cells upon activation express IL-2 and transferrin receptors, and it has been shown that the expression of these receptors is required for cell division (31) . Since the cell became insensitive to IL-2 in the presence of W6/32, it was decided to examine the expression of IL-2 and transferrin receptors. Percoll fraction 1 cells were activated with PHA and incubated with W6/32 or the control antibody anti-PAA for 48 hr and were washed with medium containing 450 mM N-acetylgalactosamine to remove the PHA present on the cell surface. These activated cells were tested by indirect immunofluorescence with anti-Tac for IL-2 receptors and with OKT9 for transferrin receptors. Table 4 shows that, in the presence of W6/32, cells did not express these receptors. Complete absence of these receptors in presence of W6/32 does not appear to be due to steric hindrance created by the anti-class I antibody because it is unable to inhibit the activation of purified T cells (Table 2) Thymidine uptake values are means ± SD. The values inside the parentheses are the percent inhibition of activated cell proliferation with W6/32. pug/ml) in the presence of W6/32 antibody, and the extent of cell proliferation was measured. W6/32 did not suppress the PMA-induced cell stimulation (data not shown), whereas it did inhibit the response to A23187 (Table 5) . Thus, W6/32 interferes with the Ca2+-dependent pathway of T-cell activation but not with the Ca2+-independent pathway activated by phorbol diester.
DISCUSSION
The present work was undertaken to study the mechanism of inhibition of T-cell responses to mitogenic lectins by anti-HLA-class I antibody. We found that the antibody W6/32 blocked PHA-induced T-cell proliferation. The inhibitory effect of antibody was due neither to the interference of the interaction between PHA and T lymphocytes nor to antibody-dependent cell cytotoxicity. Furthermore, the action of anti-HLA-class I antibody was not Fc fragment receptormediated because (i) the control antibody anti-PAA, which was the same subtype as anti-HLA-class I antibody W6/32, failed to inhibit the lymphoproliferative response, and (ii) the F(ab')2 fragment of W6/32 was also capable of suppressing the PHA activation of T cells. The antibody works by interfering with the Ca2+-dependent pathway of cell activation. Since it inhibits both the synthesis of IL-2 and IL-2 receptor expression, its action must involve the suppression of a critical event(s) during the early stages of T-cell activation that controls both IL-2 production and its receptor expression. This conclusion is supported by the time course studies, where the addition of antibody up to 24 hr after activation gives a very high level of inhibition of cell proliferation (Fig. 2 Right). Our results also suggest that the antibody-mediated suppression of this early event(s) is effective only before protein kinase C activation because: (i) antibody W6/32 is unable to inhibit cell activation induced by PMA that directly stimulates protein kinase C (34); and (ii) low levels of inhibition are obtained upon adding antibody after 2 days ofPHA activation (Fig. 2 Right), when the interaction of IL-2 with its receptor will have activated protein kinase C (34).
The action ofanti-class I antibody depends on the presence of Mol macrophages/monocytes because it fails to suppress the PHA-induced response of purified T cells. There are two likely explanations: (i) interaction between anti-class I antibody and macrophages leads to the production of an immunosuppressive factor or (ii) the antibody interferes with a T cell-macrophage interaction required for T-cell activation. The latter possibility appears to be unlikely, since the reconstitution of IL-1 did not reverse the antibody-mediated inhibition of T-cell activation. Thus, it is possible that at least some of the suppression is due to a macrophage-derived suppressor factor. Since the effect of antibody is not Fcreceptor mediated, we believe that the release of suppressor factor is the result of the binding of anti-class I antibody to class I antigens on the Mol+ adherent cell surface. This suggests that HLA class I antigens on macrophages/monocytes regulate the secretion of an immunosuppressive factor.
